N | Necrosis (%) | G1 | G2 | G3 | |
---|---|---|---|---|---|
Soft tissue sarcoma | N (Necrosis %) | ||||
No neoadjuvant therapy | 341 | 15.7 | 110 (4.1) | 114 (14.8) | 109 (28.4) |
Chemotherapy | 93 | 52.7 | 3(32.0) | 30 (39.6) | 60 (60.3) |
Radiotherapy | 80 | 45.7 | 19 (39.5) | 27 (39.3) | 34 (54.3) |
Chemo- and radiotherapy | 51 | 67.1 | 2 (75.0) | 18 (62.4) | 29 (70.6) |
134 (10.8) | 189 (26.7) | 117 (49.7) | |||
Bone sarcoma | |||||
No neoadjuvant therapy | 124 | 20.9 | 34 (6.5) | 49 (23.0) | 41 (30.4) |
Chemotherapy | 81 | 56.7 | 11 (40.6) | 70 (59.2) | |
Radiotherapy | 1 | 100 | 1 (100) | ||
Chemo- and radiotherapy | 8 | 62.8 | 2 (37.5) | 6 (71.2) | |
34 (6.5) | 63 (27.7) | 117 (49.7) |